louisiana glp-1 ileus lawsuit law office in louisiana semaglutide ileus lawyer semaglutide gi obstruction lawyer in louisiana Ozempic Stomach Paralysis louisiana semaglutide ileus class action

21 settembre 2013 [citato 30 giugno 2024];98(4):25466

Type 1 Diabetes and Severe Kidney Disease Semaglutide was designed primarily for type 2 diabetes and weight lossnot type 1 diabetes, where it poses unique risks of diabetic ketoacidosis (DKA)

On a recent episode, Dr

These tissues were within normal histological limits, with no significant signs of inflammation, necrosis, or fibrosis

Long-term use of GLP-1 receptor agonists like Ozempic has been associated with an increased risk of vitamin B12 deficiency

The SURMOUNT clinical trial program demonstrated weight loss results that shocked even the researchers running the studies, with participants on the highest dose losing an average of 22.5% of their body weight over 72 weeks